Skip to content
LILLY 325080 mg

Drawing based on the label description. No photo yet.

LILLY 3250 80 mg pill

Pill with imprint LILLY 3250 80 mg is brown & white, capsule, 18 mm and has been identified as Atomxetine Hyrochloride 10 mg. It is used for ADHD. It is supplied by Stat Rx USA LLC.

Atomxetine Hyrochloride 10 mg

Imprint
LILLY 3250 80 mg
Strength
10 mg
Used for
ADHD
Color
Brown, White
Shape
Capsule / oblong
Size
18 mm
Score
No score line
Form
Capsule
Manufacturer
Stat Rx USA LLC
NDC
16590-337, 0002-3238, 16590-337-30, 16590-337-60, 16590-337-90

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Atomxetine Hyrochloride pills and guides

What is Atomxetine Hyrochloride used for?

Atomxetine Hyrochloride is used for ADHD.

Official uses from the US prescribing label

Attention–Deficit/Hyperactivity Disorder (ADHD)

STRATTERA is indicated for the treatment of Attention–Deficit/Hyperactivity Disorder (ADHD).

The efficacy of STRATTERA Capsules was established in seven clinical trials in outpatients with ADHD: four 6 to 9-week trials in pediatric patients (ages 6 to 18), two 10-week trial in adults, and one maintenance trial in pediatrics (ages 6 to 15).

Diagnostic Considerations

A diagnosis of ADHD (DSM–IV) implies the presence of hyperactive–impulsive or inattentive symptoms that cause impairment and that were present before age 7 years. The symptoms must be persistent, must be more severe than is typically observed in individuals at a comparable level of development, must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and must be present in 2 or more settings, e.g., school (or work) and at home. The symptoms must not be better accounted for by another mental disorder.

The specific etiology of ADHD is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use not only of medical but also of special psychological, educational, and social resources. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the patient and not solely on the presence of the required number of DSM–IV characteristics.

For the Inattentive Type, at least 6 of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes, lack of sustained attention, poor listener, failure to follow through on tasks, poor organization, avoids tasks requiring sustained mental effort, loses things, easily distracted, forgetful. For the Hyperactive–Impulsive Type, at least 6 of the following symptoms must have persisted for at least 6 months: fidgeting/squirming, leaving seat, inappropriate running/climbing, difficulty with quiet activities, “on the go,” excessive talking, blurting answers, can’t wait turn, intrusive. For a Combined Type diagnosis, both inattentive and hyperactive–impulsive criteria must be met.

Need for Comprehensive Treatment Program

STRATTERA is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, social) for patients with this syndrome. Drug treatment may not be indicated for all patients with this syndrome. Drug treatment is not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Appropriate educational placement is essential in children and adolescents with this diagnosis and psychosocial intervention is often helpful. When remedial measures alone are insufficient, the decision to prescribe drug treatment medication will depend upon the physician’s assessment of the chronicity and severity of the patient’s symptoms.

From the FDA-approved label on DailyMed (published Jun 14, 2010).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows LILLY 3250 80 mg. The parts can be split between the two sides, so turn the pill over and check both.
  • It is brown & white, capsule, 18 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Strattera.

Ingredients

Active: Atomoxetine Hydrochloride

Inactive: Starch, Corn, Dimethicone, Gelatin, Sodium Lauryl Sulfate, Ferric Oxide Yellow, Ferric Oxide Red, Titanium Dioxide

Other pills with imprint LILLY 3250 80 mg

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.